DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20150009

Antidepressant drugs: evaluation of price variation

Bhumika Jayantilal Patel, Kalpesh Himatlal Patel, Manubhai P. Patel

Abstract


Background: Drugs are available in many different brands and costs of all brands are different. Patients of depression have to take the antidepressant drug for a long duration. If the cost of a drug is high patient has to pay more money for complete treatment. It can result in noncompliance and treatment failure. This study was aimed to evaluate the cost of antidepressant drugs of different classes and to analyze price variation in various antidepressant drugs available in India. Hence, we decided to do the study of price variations of antidepressant drugs.

Methods: We had evaluated the cost of a different class of antidepressant drugs. Current Index of Medical Specialties October-December 2014 and Indian Drug Review 2015 issue 1 drug manuals were used to derive the cost of antidepressant drugs. Data about the cost of antidepressant drugs were collected for all the strength and dosage forms. The maximum price and minimum price for the different antidepressant drugs were identified, and calculation for the percentage of price variation was done.

Results: Maximum percentage of price variation in different groups were 900% in reboxetine 2 mg (tricyclic antidepressants group), 495.23% in escitalopram 10 mg (selective serotonin reuptake inhibitors group), 318.66% in duloxetine 20 mg capsules (serotonin and noradrenaline reuptake inhibitors group), 243.58% in moclobemide 150 mg tablet (reversible monoamine oxidase-A inhibitor), 84.93% in bupropion 150 mg sustained-release tablet (atypical antidepressants group). In combination escitalopram 10 mg + clonazepam 0.5 mg shows maximum price variation of 1101.92%.

Conclusion: Price variation was wide for antidepressant drugs. Generic drug prescribing can decrease the expenditure of patient on the drug. Prescribers should be provided updated knowledge of the cost of different drugs. Modifications in pharmaceutical policy are required, and prices of the drug should be controlled in effective way for all the drugs.


Keywords


Price variation, Antidepressant drugs, Brands

Full Text:

PDF

References


Pharmaceuticals, 2014. India in Business Ministry of External Affairs, Govt. of India, Investment and Technology Promotion Division. Available at http://www.indiainbusiness.nic.in/newdesign/index.php?param=industryservices_landing/347/1. Accessed 25 March 2015.

Sharma S. Making Medicines Affordable. Low cost Generic Drugs Initiative in Rajasthan. Available at http://www.rmsc.nic.in/knowledge/generic%20note.pdf. Accessed 25 March 2015.

World Health Statistics. Geneva: World Health Organization; 2009. Available at http://www.who.int/entity/whosis/whostat/EN_W HS09_Full.pdf. Accessed 25 March 2015.

Grover S, Dutt A, Avasthi A. An overview of Indian research in depression. Indian J Psychiatry. 2010;52 Suppl 1:S178-88.

Poongothai S, Pradeepa R, Ganesan A, Mohan V. Prevalence of depression in a large urban South Indian population – the Chennai Urban rural epidemiology study (CURES-70). PLoS One. 2009 28;4:e7185.

Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global Burden of Disease and Risk Factors. Washington: the World Bank; 2006.

Pincus HA, Tanielian TL, Marcus SC, Olfson M, Zarin DA, Thompson J, et al. Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. JAMA. 1998;279(7):526-31.

Costa J, Rosa MM, Ferreira JJ, Sampaio C, Vaz Carneiro A. Cardiac effects of acute poisoning with tricyclic antidepressants: systematic review of the literature. Part I. Rev Port Cardiol. 2001;20:671-8.

Rao KS, Nundy M, Dua AS, National Commission on Macroeconomics and Health, Financing and delivery of health care services in India. New Delhi: ministry of Health & Family Welfare, Government of India, Delivery of Health Services in the Private Sector; 2005: 89-104.

Drug Price Control Order, 2013. Available at http://www.nppaindia.nic.in/DPCO2013.pdf. Accessed 2 March 2015.

Compendium of Notified Prices of Scheduled Drugs, 2015. Available at http://www.nppaindia.nic.in. Accessed 17 March 2015.

Jana S, Mondal P. Pharmacoeconomics: the need to sensitize undergraduate medical students. Indian J Pharmacol 2005;37:277-8.

Tondare SB, Bhave KA. Cost analysis of oral antipsychotic drugs available in the Indian market. Int J Pharm Sci Rev Res. 2014;29(2):267-70.

Date AP, Mahajan HM, Dashputra AV, Bhosale RR. Study of variation in price of various antidiabetic drugs available in Indian market. Int J Basic Clin Pharm. 2015;4:36-40.

Roy N, Madhiwala N. Promotional Practices of Pharmaceutical Firms in India. Forum for Medical Ethics, Mumbai, 2004. Available at http://www.ijme.in/132ss063.html. Accessed 25 March 2015.

Lofolm PW, Katzug BG. Rational prescribing and prescription writing. In: katzung BG, editor. Basic and Clinical Pharmacology. 9th ed. New York: McGraw Hill; 2004: 1091-100.